Multidisciplinary Management of Skull Base and Superstructure Tumors

  • Giulio Cantù
  • Carlo L. Solero
  • Stefano Riccio
  • Sarah Colombo
  • Madia Pompilio
Chapter

Abstract

Malignant tumors of the paranasal sinuses are rare, accounting for only 3% of all the head and neck malignancies. As a consequence, no report of a randomized clinical trial about different treatments has been published, and the chance to perform such a trial is remote. However, the combination of surgery and (chemo)-radiotherapy seems to offer better local control than radiotherapy alone.The treatment of skull base tumors is, by definition, a multidisciplinary work. Even in cases were surgery may be the only treatment, at least a neurosurgeon and a head and neck surgeon must collaborate to reach good results avoiding complications. Plastic and reconstructive surgeons, radiologists, anesthesiologists, critical care and rehabilitations experts, and nurses are also indispensable. Moreover, the quite steady indication for pre- or postoperative (chemo)-radiotherapy involves the involvement of medical oncologists and radiotherapists in the therapeutic team.This chapter will demonstrate in details the above-­mentioned principles, mentioning the more recent papers on this topic and my own large experience in the treatment of malignant skull base tumors. Moreover, I will take into ­consideration the most frequent histologic types and their different etiology and standard or experimental treatment.

Keywords

Sinonasal cancer Skull base Paranasal sinus Reconstructive surgery 

References

  1. 1.
    Muir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci. 1980;5:195–211.PubMedCrossRefGoogle Scholar
  2. 2.
    Newman DA. A case of adeno-carcinoma of the left inferior turbinate boby, and perforation of the nasal septum, in the person of a worker in chrome pigments. Glasgow Med J. 1890;33:469–70.Google Scholar
  3. 3.
    ‘t Mannetje A, Kogevinas M, Luce D, et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med. 1999;36(1):101–7.PubMedGoogle Scholar
  4. 4.
    Acheson ED, Cowdell RH, Hadfield E, Macbeth RG. Nasal cancer in woodworkers in the furniture industry. Br Med J. 1968;2:587–96.PubMedCrossRefGoogle Scholar
  5. 5.
    Hadfield EH. A study of adenocarcinoma of the paranasal sinuses in woodworkers in the furniture industry. Ann R Coll Surg Engl. 1970;46(6):301–19.PubMedGoogle Scholar
  6. 6.
    Klintenberg C, Olofsson J, Hellquist H, et al. Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer. 1984;54(3):482–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Luce D, Leclerc A, Morcet JF, et al. Occupational risk factors for sinonasal cancer: a case-control study in France. Am J Ind Med. 1992;21(2):163–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Acheson ED. Nasal cancer in the furniture and boot and shoe manufacturing industries. Prev Med. 1976;5(2):295–315.PubMedCrossRefGoogle Scholar
  9. 9.
    Hernberg S, Westerholm P, Shultz-Larsen K, et al. Nasal and sinonasal cancer. Connection with occupational exposures in Denmark, Finland and Sweden. Scand J Work Environ Health. 1983;9(4):315–26.PubMedGoogle Scholar
  10. 10.
    Hadfield EH, Macbeth RG. Adenocarcinoma of the ethmoids in furniture workers. Ann Otol Rhinol Laryngol. 1971;80(5):699–703.PubMedGoogle Scholar
  11. 11.
    Bimbi G, Saraceno MS, Riccio S, et al. Adenocarcinoma of the ethmoid sinus: an occupational disease. Acta Otorhinolaryngol Ital. 2004;24(4):199–203.PubMedGoogle Scholar
  12. 12.
    Voss R, Stenersen T, Roald Hoppedal B, et al. Sinonasal cancer and exposure to softwood. Acta Otolaryngol. 1985;99(1–2):172–88.PubMedCrossRefGoogle Scholar
  13. 13.
    Carton M, Goldberg M, Luce D. Occupational exposure to wood dust. Health effects and exposure limit values. Rev Epidemiol Sante Publique. 2002;50(2):159–78.PubMedGoogle Scholar
  14. 14.
    Roux FX, Pages JC, Nataf F, et al. Malignant ethmoid-sphenoidal tumors. 130 cases. Retrospective study. Neurochirurgie. 1997;43(2):100–10.PubMedGoogle Scholar
  15. 15.
    Suarez C, Suarez C, Llorente JL, Fernandez De Leon R, et al. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck. 2004;26(2):136–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Cantu G, Solero CL, Miceli R, et al. Which classification for ethmoid malignant tumors involving the anterior skull base? Head Neck. 2005;27(3):224–31.PubMedCrossRefGoogle Scholar
  17. 17.
    Cheesman AD. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses. Head Neck Surg. 1986;8(6):429–35.PubMedCrossRefGoogle Scholar
  18. 18.
    McCutcheon IE, Blacklock JB, Weber RS, et al. Anterior transcranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery. 1996;38(3):471–9. discussion 479–80.PubMedGoogle Scholar
  19. 19.
    Bentz BG, Bilsky MH, Shah JP, et al. Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head Neck. 2003;25(7):515–20.PubMedCrossRefGoogle Scholar
  20. 20.
    Donald PJ. Complications in skull base surgery for malignancy. Laryngoscope. 1999;109(12):1959–66.PubMedCrossRefGoogle Scholar
  21. 21.
    Irish JC, Gullane PJ, Gentili F, et al. Tumors of the skull base: outcome and survival analysis of 77 cases. Head Neck. 1994;16(1):3–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Bridger GP, Kvok B, Baldwin M, et al. Craniofacial resection for paranasal sinus cancers. Head Neck. 2000;22(8):772–80.PubMedCrossRefGoogle Scholar
  23. 23.
    Blot WJ, Chow WH, McLaughlin JK. Wood dust and nasal cancer risk. A review of the evidence from North America. J Occup Environ Med. 1997;39(2):148–56.PubMedCrossRefGoogle Scholar
  24. 24.
    Nylander LA, Dement JD. Carcinogenetics effects of wood dust: review and discussion. Am J Ind Med. 1993;24(5):619–47.PubMedCrossRefGoogle Scholar
  25. 25.
    Pastore E, Perrone F, Orsenigo M, et al. Polymorphisms of metabolizing enzymes and susceptibility to ethmoid intestinal-type adenocarcinoma in professionally exposed patients. Transl Oncol. 2009;2(2):84–8.PubMedGoogle Scholar
  26. 26.
    Barnes L, Everson JW, Reichart P, et al. World Health Organization classification of tumours: pathology & genetics-head and neck tumours. Lyon, France: IARC Press; 2005.Google Scholar
  27. 27.
    Dulguerov P, Jacobsen MS, Allal AS, et al. Nasal and paranasal sinus carcinoma: are we making progress? Cancer. 2001;92(12):3012–29.PubMedCrossRefGoogle Scholar
  28. 28.
    Katz TS, Mendenhall WM, Morris CG, et al. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002;24(9):821–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Schantz SP, Harrison LB, Forastiere AA. Tumors of the nasal cavity and paranasal sinuses. In: De Vita Jr VT, Hellman S, Rosemberg SA, editors. Cancer. Principles & practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 819–24.Google Scholar
  30. 30.
    Le QT, Fu KK, Kaplan MJ, Terris DJ, et al. Lymph none metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys. 2000;46(3):541–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Paulino AC, Fisher SG, Marks JE. Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus? Int J Radiat Oncol Biol Phys. 1997;39(2):283–9.PubMedGoogle Scholar
  32. 32.
    Kim GE, Chung EJ, Lim JJ, et al. Clinical significance of neck node metastasis in squamous cell carcinoma of the maxillary antrum. Am J Otolaryngol. 1999;20(6):383–90.PubMedCrossRefGoogle Scholar
  33. 33.
    Bhattacharyya N. Factor affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg. 2003;61(9):10016–1021.CrossRefGoogle Scholar
  34. 34.
    Cantù G, Bimbi G, Miceli R, et al. Lymph node metastases in paranasal sinuses malignant tumors: prognostic value and treatment. Arch Otolaryngol Head Neck Surg. 2008;134(2):170–7.PubMedCrossRefGoogle Scholar
  35. 35.
    del Regato JA. Roentgentherapy in epitheliomas of the maxillary sinus. Surg Gynecol Obstet. 1937;65:657–65.Google Scholar
  36. 36.
    Sisson GA, Johnson NE, Amiri CS. Cancer of the maxillary sinus. Clinical classification and management. Ann Otol Rhinol Laryngol. 1963;72(12):1050–9.PubMedGoogle Scholar
  37. 37.
    Sakai S, Hamasaki Y. Proposal for the classification of carcinoma of the paranasal sinuses. Acta Otolaryngol (Stockolm). 1967;63(1):42–8.CrossRefGoogle Scholar
  38. 38.
    Lederman M. Cancer of the upper jaw and nasal chambers. Proc R Soc Med. 1969;62(1):65–72.PubMedGoogle Scholar
  39. 39.
    Rubin P. Cancer of the head and neck: nose, paranasal sinuses. JAMA. 1972;219(3):336–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Chandler JR, Guillamondegui OM, Sisson GA, et al. Clinical staging of cancer of the head and neck: a new “new” system. Am J Surg. 1976;132(4):525–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Harrison DF. Critical look at the classification of maxillary sinus carcinomata. Ann Otol Rhinol Laryngol. 1978;87(1pt1):3–9.PubMedGoogle Scholar
  42. 42.
    Sebileau P. Les formes cliniques du cancer du sinus maxillaire. Annales malades d’oreille, du larynx, nez et pharynx. 1906;32:430–50.Google Scholar
  43. 43.
    Öhngren LG. Malignant tumors of the maxillary-ethmoidal region. Acta Otolaryngol (Stockolm). 1933;19:1–476.Google Scholar
  44. 44.
    AJCC. Manual for staging of cancer 1977. Chicago, IL: American Joint Committee; 1977. p. 45–8.Google Scholar
  45. 45.
    Beahrs OH, Myers MH. AJCC manual for staging of cancer. 2nd ed. Philadelphia, PA: J.B. Lippincott Company; 1983. p. 43–8.Google Scholar
  46. 46.
    Beahrs OH, Henson DE, Hutter RVP, et al. AJCC manual for staging of cancer. 3rd ed. Philadelphia, PA: J.B. Lippincott Company; 1988. p. 45–50.Google Scholar
  47. 47.
    Beahrs OH, Henson DE, Hutter RVP, et al. AJCC manual for staging of cancer. 4th ed. Philadelphia, PA: J.B. Lippincott Company; 1992. p. 45–8.Google Scholar
  48. 48.
    Hermanek P, Sobin LH. UICC TNM classification of malignant tumours. Berlin: Springer; 1987. p. 27–9.Google Scholar
  49. 49.
    Sisson GA, Toriumi DM, Atiyah RA. Paranasal sinus malignancy: a comprehensive update. Laryngoscope. 1989;99(2):143–50.PubMedCrossRefGoogle Scholar
  50. 50.
    Spiro JD, Soo KC, Spiro RH. Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck. 1995;17(2):114–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37(3):1571–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Biller HF, Lawson W, Sachdev VP, et al. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope. 1990;100(11):1199–201.PubMedCrossRefGoogle Scholar
  53. 53.
    Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970–1990. Laryngoscope. 1992;102(8):843–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Ellingwood KE, Million RR. Cancer of the nasal cavity and ethmoid/sphenoid sinuses. Cancer. 1979;43(4):1517–26.PubMedCrossRefGoogle Scholar
  55. 55.
    Roux FX, Brasnu D, Menard M, et al. Combined approach to malignant tumors of the ethmoid and other paranasal sinuses. Principles and results. Ann Otolaryngol Chir Cervicofac. 1991;108(5):292–7.PubMedGoogle Scholar
  56. 56.
    Cantu G, Solero CL, Salvatori P, et al. A new classification of malignant ethmoid tumors. 3rd European Skull Base Congress. London, 9–11 April 1997. Skull Base Surg. 1997;7 Suppl 2:33.Google Scholar
  57. 57.
    American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia, PA: Lippincot-Raven; 1997.Google Scholar
  58. 58.
    Sobin LH, Wettekind C, editors. TNM classification of malignant tumours. 5th ed. New York, NY: John Wiley & Sons Inc; 1997.Google Scholar
  59. 59.
    American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag; 2002.Google Scholar
  60. 60.
    UICC. TNM classification of malignant tumours. 6th ed. New York, NY: Wiley-Liss; 2002.Google Scholar
  61. 61.
    Cantù G, Solero CL, Miceli R, et al. Which classification for ethmoid malignant tumors involving the anterior skull base? Head Neck. 2005;27(3):224–31.PubMedCrossRefGoogle Scholar
  62. 62.
    Dulguerov P, Allal AS. Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg. 2006;14(2):67–72.PubMedGoogle Scholar
  63. 63.
    Cohen ZR, Marmor WE, Fuller GN, et al. Misdiagnosis of olfactory neuroblastoma. Neurosurg FocusNeurosurg Focus. 2002;12(5):e3.Google Scholar
  64. 64.
    Ganly I, Patel SG, Singh B, et al. Craniofacial resection for malignant paranasal sinus tumors: report of an International Collaborative Study. Head Neck. 2005;27(7):575–84.PubMedCrossRefGoogle Scholar
  65. 65.
    Cantù G, Solero CL, Mariani L, et al. Anterior craniofacial resection for malignant ethmoid tumors – a series of 91 patients. Head Neck. 1999;21(3):185–91.PubMedCrossRefGoogle Scholar
  66. 66.
    Patel SG, Singh B, Polluri A, et al. Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer. 2003;98(6):1179–87.PubMedCrossRefGoogle Scholar
  67. 67.
    Waldron J, Witterick I. Paranasal sinus cancer: caveats and controversies. World J Surg. 2003;27(7):849–55.PubMedCrossRefGoogle Scholar
  68. 68.
    Waldron JN, O’Sullivan B, Warde P, et al. Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy. Int J Radiat Oncol Biol Phys. 1998;41(2):361–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Stell PM. History of surgery of the upper jaw. In: Harrison D, Lund VJ, editors. Tumours of the upper jaw. Edinburgh: Ed Churchill Livingstone; 1993. p. 1–15.Google Scholar
  70. 70.
    Conley JJ. The surgical approach to the pterygoid area. Ann Surg. 1956;144(1):39–43.PubMedCrossRefGoogle Scholar
  71. 71.
    Crockett DJ. Surgical approach to the back of the maxilla. Br J Surg. 1963;50:819–21.PubMedCrossRefGoogle Scholar
  72. 72.
    Dingman DL, Conley JJ. Lateral approach to the pterygomaxillary region. Ann Otol Rhinol Laryngol. 1970;79(5):967–9.PubMedGoogle Scholar
  73. 73.
    Smith RR, Klopp CT, Williams JM. Surgical treatment of cancer of the frontal sinus and adjacent areas. Cancer. 1954;7(5):991–4.PubMedCrossRefGoogle Scholar
  74. 74.
    Malecki J. New trends in frontal sinus surgery. Acta Otolaryngol. 1959;50(2):137–40.PubMedCrossRefGoogle Scholar
  75. 75.
    Ketcham AS, Wilkins RH, Van Buren JM, et al. A combined intracranial facial approach to the paranasal sinuses. Am J Surg. 1963;106:698–703.PubMedCrossRefGoogle Scholar
  76. 76.
    Patel SG, Singh B, Polluri A, et al. Craniofacial surgery for malignant skull base tumors. Report of an International Collaborative Study. Cancer. 2003;98(6):1179–87.PubMedCrossRefGoogle Scholar
  77. 77.
    Ganly I, Patel SG, Singh B, et al. Craniofacial resection for malignant paranasal sinus tumors: report of an International Collaborative Study. Head Neck. 2005;27(7):575–84.PubMedCrossRefGoogle Scholar
  78. 78.
    Ketcham AS, Van Buren JM. Tumors of the paranasal sinuses: a therapeutic challenge. Am J Surg. 1985;150(4):406–13.PubMedCrossRefGoogle Scholar
  79. 79.
    Stern SJ, Goepfert H, Clayman G, et al. Orbital preservation in maxillectomy. Otolaryngol Head Neck Surg. 1993;109(1):111–5.PubMedGoogle Scholar
  80. 80.
    Cantu G, Solero CL, Riccio S, et al. Surgery for malignant maxillary tumors involving the middle cranial fossa. Skull Base. 2010;20(2):55–60.Google Scholar
  81. 81.
    Nicolai P, Castelnuovo P, Lombardi D, et al. Role of endoscopic surgery in the management of selected malignant epithelial neoplasms of the naso-ethmoidal complex. Head Neck. 2007;29(12):1075–82.PubMedCrossRefGoogle Scholar
  82. 82.
    Nicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol. 2008;22(3):308–16.PubMedCrossRefGoogle Scholar
  83. 83.
    Choi HR, Sturgis EM, Rashid A, et al. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol. 2003;34(11):1101–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Kennedy MT, Jordan RCK, Berean KW, et al. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol. 2004;57(9):932–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Batsakis JG. Mucous gland tumors of the nose and paranasal sinuses. Ann Otol Rhinol Laryngol. 1970;79(3):557–62.PubMedGoogle Scholar
  86. 86.
    Katz TS, Mendenhall WM, Morris CG, et al. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002;24(9):821–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Tanzler ED, Morris CG, Orlando CA, et al. Management of sinonasal undifferentiated carcinoma. Head Neck. 2008;30(5):595–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Guntinas-Lichius O, Kreppel MP, Stuetzer H, et al. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol. 2007;33(2):222–8.PubMedGoogle Scholar
  89. 89.
    Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting – the MSKCC experience. Int J Radiat Oncol Biol Phys. 2007;67(3):691–702.PubMedCrossRefGoogle Scholar
  90. 90.
    Douglas JC, Laramore GE, Austin-Seymour M, et al. Neutron radiotherapy for adenoid cystic carcinoma of the minor salivary gland. Int J Radiat Oncol Biol Phys. 1996;36:87–93.PubMedCrossRefGoogle Scholar
  91. 91.
    Douglas JG, Laramore GE, Austin-Seymour M, et al. Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46(3):551–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Pommier P, Liebsch NJ, Deschler DG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132(11):1242–9.PubMedCrossRefGoogle Scholar
  93. 93.
    Brada M, Pijls-Johannesma M, De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. J Clin Oncol. 2007;25(8):965–70.PubMedCrossRefGoogle Scholar
  94. 94.
    Sato Y, Morita M, Takahashi HO, et al. Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer. 1970;25(3):571–9.PubMedCrossRefGoogle Scholar
  95. 95.
    Sakai S, Hohki A, Fuchihata H, et al. Multidisciplinary treatment of maxillary sinus carcinoma. Cancer. 1983;52(8):1360–4.PubMedCrossRefGoogle Scholar
  96. 96.
    Kondo M, Ogawa K, Inuyama Y, et al. Prognostic factors influencing relapse of squamous cell carcinoma of the maxillary sinus. Cancer. 1985;55(1):190–6.PubMedCrossRefGoogle Scholar
  97. 97.
    Tsujii H, Kamada T, Arimoto T, et al. The role of radiotherapy in the management of maxillary sinus carcinoma. Cancer. 1986;57(12):2261–6.PubMedCrossRefGoogle Scholar
  98. 98.
    Shibuya H, Suzuki S, Horiuchi J, et al. Reappraisal of trimodal combination therapy for maxillary sinus carcinoma. Cancer. 1982;50(12):2790–4.PubMedCrossRefGoogle Scholar
  99. 99.
    Konno A, Ishikawa K, Terada N, et al. Analysis of long-term results of our combination therapy for squamous cell cancer of the maxillary sinus. Acta Otolaryngol Suppl. 1998;537:57–66.PubMedGoogle Scholar
  100. 100.
    Samant S, Robbins KT, Vang M, et al. Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg. 2004;130(8):948–55.PubMedCrossRefGoogle Scholar
  101. 101.
    Knegt PP, de Jong PC, van Andel JG, et al. Carcinoma of the paranasal sinuses. Results of a prospective pilot study. Cancer. 1985;56(1):57–62.PubMedCrossRefGoogle Scholar
  102. 102.
    Knegt PP, Ah-See KW, vd Velden LA LA, et al. Adenocarcinoma of the ethmoidal sinus complex: surgical debulking and topical fluorouracil may be the optimal treatment. Arch Otolaryngol Head Neck Surg. 2001;127(2):141–6.PubMedGoogle Scholar
  103. 103.
    Almeyda R, Capper J. Is surgical debridement and topical 5 fluorouracil the optimum treatment for woodworkers’ adenocarcinoma of the ethmoid sinuses? A case-controlled study of a 20-year experience. Clin Otolaryngol. 2008;33(5):435–41.PubMedCrossRefGoogle Scholar
  104. 104.
    Licitra L, Locati LD, Bossi P, et al. Head and neck tumors other than squamous cell carcinoma. Curr Opin Oncol. 2004;16(3):236–41.PubMedCrossRefGoogle Scholar
  105. 105.
    Rosen A, Vokes EE, Scher N, et al. Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg. 1993;119(7):743–6.PubMedGoogle Scholar
  106. 106.
    Björk-Eriksson T, Mercke C, Petruson B, et al. Potential impact on tumor control and organ preservation with cisplatin and 5-­fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa. A prospective pilot study. Cancer. 1992;70(11):2615–20.PubMedCrossRefGoogle Scholar
  107. 107.
    Licitra L, Locati LD, Cavina R, et al. Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol. 2003;14(3):367–72.PubMedCrossRefGoogle Scholar
  108. 108.
    Licitra L, Suardi S, Bossi P, et al. Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma. J Clin Oncol. 2004;22(24):4901–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Giulio Cantù
    • 1
  • Carlo L. Solero
  • Stefano Riccio
  • Sarah Colombo
  • Madia Pompilio
  1. 1.Department of Cranio-Maxillo-Facial SurgeryFondazione IRCCS Istituto Nazionale dei Tumori, National Cancer InstituteMilanoItaly

Personalised recommendations